Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey

Venetoclax, the best established BH3-mimetic, is a practice-changing proapoptotic drug in blood cancers in adults. In paediatrics the data are fewer but exciting results were recently presented in relapsed or refractory leukaemias demonstrating significant clinical activity. Importantly, the in-terv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobeff, Katarzyna, Pastorczak, Agata, Urbanska, Zuzanna, Balwierz, Walentyna, Juraszewska, Edyta, Wachowiak, Jacek, Derwich, Katarzyna, Samborska, Magdalena, Kalwak, Krzysztof, Dachowska-Kalwak, Iwona, Laguna, Paweł, Malinowska, Iwona, Smalisz, Katarzyna, Gozdzik, Jolanta, Oszer, Aleksandra, Urbanski, Bartosz, Zdunek, Maciej, Szczepanski, Tomasz, Mlynarski, Wojciech, Janczar, Szymon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137026/
https://www.ncbi.nlm.nih.gov/pubmed/37189994
http://dx.doi.org/10.3390/children10040745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137026/
https://www.ncbi.nlm.nih.gov/pubmed/37189994
http://dx.doi.org/10.3390/children10040745

Ejemplares similares